259 related articles for article (PubMed ID: 28753070)
21. A prospective study of the effects of carbocysteine lysine salt on frequency of exacerbations in COPD patients treated with or without inhaled steroids.
Paone G; Lanata L; Saibene F; Toti S; Palermo P; Graziani C; Flore MC; Ramaccia M; Puglisi G
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6727-6735. PubMed ID: 31378916
[TBL] [Abstract][Full Text] [Related]
22. N-acetylcysteine Treatment in Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis/Pre-COPD: Distinct Meta-analyses.
Papi A; Alfano F; Bigoni T; Mancini L; Mawass A; Baraldi F; Aljama C; Contoli M; Miravitlles M
Arch Bronconeumol; 2024 May; 60(5):269-278. PubMed ID: 38555190
[TBL] [Abstract][Full Text] [Related]
23. Acetylcysteine and carbocysteine for acute upper and lower respiratory tract infections in paediatric patients without chronic broncho-pulmonary disease.
Duijvestijn YC; Mourdi N; Smucny J; Pons G; Chalumeau M
Cochrane Database Syst Rev; 2009 Jan; (1):CD003124. PubMed ID: 19160217
[TBL] [Abstract][Full Text] [Related]
24. Acetylcysteine and carbocysteine for acute upper and lower respiratory tract infections in paediatric patients without chronic broncho-pulmonary disease.
Chalumeau M; Duijvestijn YC
Cochrane Database Syst Rev; 2013 May; (5):CD003124. PubMed ID: 23728642
[TBL] [Abstract][Full Text] [Related]
25. Prevention of exacerbations of COPD with pharmacotherapy.
Miravitlles M
Eur Respir Rev; 2010 Jun; 19(116):119-26. PubMed ID: 20956180
[TBL] [Abstract][Full Text] [Related]
26. Exacerbations of chronic obstructive pulmonary disease.
Wedzicha JA; Donaldson GC
Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
[TBL] [Abstract][Full Text] [Related]
27. Mucoactive therapy in COPD.
Decramer M; Janssens W
Eur Respir Rev; 2010 Jun; 19(116):134-40. PubMed ID: 20956182
[TBL] [Abstract][Full Text] [Related]
28. Multifaceted Beneficial Effects of Erdosteine: More than a Mucolytic Agent.
Cazzola M; Page C; Rogliani P; Calzetta L; Matera MG
Drugs; 2020 Nov; 80(17):1799-1809. PubMed ID: 33025535
[TBL] [Abstract][Full Text] [Related]
29. Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease.
Poole PJ; Black PN
Cochrane Database Syst Rev; 2003; (2):CD001287. PubMed ID: 12804402
[TBL] [Abstract][Full Text] [Related]
30. Oxidation pathway and exacerbations in COPD: the role of NAC.
Matera MG; Calzetta L; Cazzola M
Expert Rev Respir Med; 2016; 10(1):89-97. PubMed ID: 26567752
[TBL] [Abstract][Full Text] [Related]
31. Erdosteine reduces inflammation and time to first exacerbation postdischarge in hospitalized patients with AECOPD.
Moretti M; Fagnani S
Int J Chron Obstruct Pulmon Dis; 2015; 10():2319-25. PubMed ID: 26604731
[TBL] [Abstract][Full Text] [Related]
32. Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial.
Zheng JP; Wen FQ; Bai CX; Wan HY; Kang J; Chen P; Yao WZ; Ma LJ; Li X; Raiteri L; Sardina M; Gao Y; Wang BS; Zhong NS;
Lancet Respir Med; 2014 Mar; 2(3):187-94. PubMed ID: 24621680
[TBL] [Abstract][Full Text] [Related]
33. Carbocisteine for acute exacerbations of COPD.
Waller P; Suissa S
Lancet; 2008 Nov; 372(9650):1630; author reply 1631-2. PubMed ID: 18994655
[No Abstract] [Full Text] [Related]
34. A PEACE-ful solution to COPD exacerbations?
Albert P; Calverley P
Lancet; 2008 Jun; 371(9629):1975-6. PubMed ID: 18555897
[No Abstract] [Full Text] [Related]
35. Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease.
Poole PJ; Black PN
Cochrane Database Syst Rev; 2000; (2):CD001287. PubMed ID: 10796634
[TBL] [Abstract][Full Text] [Related]
36. Preventing exacerbations of chronic bronchitis and COPD: therapeutic potential of mucolytic agents.
Poole PJ; Black PN
Am J Respir Med; 2003; 2(5):367-70. PubMed ID: 14719989
[TBL] [Abstract][Full Text] [Related]
37. Carbocisteine for acute exacerbations of COPD.
Mohapatra PR; Aggarwal D
Lancet; 2008 Nov; 372(9650):1630-1; author reply 1631-2. PubMed ID: 18994656
[No Abstract] [Full Text] [Related]
38. Prediction and prevention of exacerbations and mortality in patients with COPD.
Kostikas K; Clemens A; Patalano F
Expert Rev Respir Med; 2016 Jul; 10(7):739-53. PubMed ID: 27135786
[TBL] [Abstract][Full Text] [Related]
39. Mucolytics for acute exacerbations of chronic obstructive pulmonary disease: a meta-analysis.
Papadopoulou E; Hansel J; Lazar Z; Kostikas K; Tryfon S; Vestbo J; Mathioudakis AG
Eur Respir Rev; 2023 Mar; 32(167):. PubMed ID: 36697209
[TBL] [Abstract][Full Text] [Related]
40. [Effect of mucolytic therapy on the production of reactive oxygen species in the blood of patients with an exacerbation of chronic obstructive pulmonary disease].
Farkhutdinov UR; Farkhutdinov RR; Petriakov VV; Farkhutdinov ShU; Mirkhaĭdarov AM
Ter Arkh; 2010; 82(3):29-32. PubMed ID: 20564918
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]